Mesenchymal stromal cells (MSCs) are known for their immunomodulatory activity. Here, we report that MSCs isolated from the amniotic membrane of human term placenta (hAMSCs) impact CD8 T cell fate through a multifaceted mechanism. We observed that hAMSCs are able to impact the metabolism of naive CD8 lymphocytes by downregulating the phosphorylation of mTOR and AKT, thus blocking cell differentiation. This effect is due to the ability of hAMSCs to reduce the expression of two receptors, IL-12Rβ1 and IL-2RA, resulting in reduced phosphorylation of STAT4 and STAT5. In addition, hAMSCs reduce the expression of two transcriptional factors, Tbet and Eomes, directly involved in early effector cell commitment. Our results unravel an unknown feature of MSCs, offering alternative mechanistic insights into the effects of MSCs for the treatment of diseases characterized by an altered activation of memory subsets, such as autoimmune diseases and graft versus host disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10709131 | PMC |
| http://dx.doi.org/10.1016/j.isci.2023.108483 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Influence of the Surface Topography of Titanium Dental Implants on the Behavior of Human Amniotic Stem Cells.
Int J Mol Sci
July 2024
Department of Stomatology, Faculty of Dentistry, University of Seville, 41004 Sevilla, Spain.
Article Synopsis
- - The study focuses on how different titanium surface treatments (MACH, AE, GBLAST, GBLAST + AE) influence the effectiveness of dental implants by affecting osseointegration, which is essential for successful implantation.
- - Four surface types were analyzed for their physical properties, revealing that GBLAST and GBLAST + AE surfaces exhibited better roughness and microhardness, which are important for cellular interaction and implant stability.
- - The research found that human amniotic mesenchymal stem cells (hAMSCs) showed better viability and osteogenic differentiation on GBLAST surfaces compared to human epithelial stem cells (hAECs), indicating that specific implant surface treatments can enhance bone-forming capabilities.
Beneficial effects of bioactive peptides extracted from Spirulina platensis and Gracilaria gracilis algae on bone regeneration/osteogenic differentiation of mesenchymal stem cells.
Tissue Cell
August 2024
Department of Biology, Faculty of Sciences, Golestan University, Gorgan, Iran.
Mesenchymal stem cells are used in the treatment of many diseases, particularly in the repair of bone injuries. Algae with various medicinal applications are considered important natural resources. There is limited research on the effects of bioactive peptides from algae extraction on mesenchymal stem cells.
View Article and Find Full Text PDFProteomic analysis and functional validation reveal distinct therapeutic capabilities related to priming of mesenchymal stromal/stem cells with IFN-γ and hypoxia: potential implications for their clinical use.
Front Cell Dev Biol
May 2024
Research Department, IRCCS ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta Specializzazione), Palermo, Italy.
Mesenchymal stromal/stem cells (MSCs) are a heterogeneous population of multipotent cells that can be obtained from various tissues, such as dental pulp, adipose tissue, bone marrow and placenta. MSCs have gained importance in the field of regenerative medicine because of their promising role in cell therapy and their regulatory abilities in tissue repair and regeneration. However, a better characterization of these cells and their products is necessary to further potentiate their clinical application.
View Article and Find Full Text PDFHypoxia preconditioning of human amniotic mesenchymal stem cells enhances proliferation and migration and promotes their homing via the HGF/C-MET signaling axis to augment the repair of acute liver failure.
Tissue Cell
April 2024
Department of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Infectious and Tropical Diseases, The Second Affiliated Hospital of Hainan Medical University, Hainan, China. Electronic address:
Background: Transplantation of mesenchymal stem cells (MSCs) is a newly developed strategy for treating acute liver failure (ALF). Nonetheless, the low survival rate of MSCs after transplantation and their poor homing to damaged tissues limit the clinical application of MSCs. The research assessed whether hypoxic preconditioning (HPC) can improve the biological activity of human amniotic mesenchymal stem cells (hA-MSCs), promote their homing ability to the liver of mice with ALF, and influence liver tissue repair.
View Article and Find Full Text PDFHuman amniotic mesenchymal stromal cell-derived exosomes promote neuronal function by inhibiting excessive apoptosis in a hypoxia/ischemia-induced cerebral palsy model: A preclinical study.
Biomed Pharmacother
April 2024
Department of Pediatric Rehabilitation, Huai'an Maternal and Child Health Care Center, Huai'an, Jiangsu 223021, China; Affiliated Hospital of Yang Zhou University Huai'an Maternal and Child Health Care Center, Huai'an, Jiangsu 223021, China. Electronic address:
Background: Cerebral palsy (CP) is a condition resulting from perinatal brain injury and can lead to physical disabilities. Exosomes derived from human amniotic mesenchymal stromal cells (hAMSC-Exos) hold promise as potential therapeutic options.
Objective: This study aimed to investigate the impact of hAMSC-Exos on neuronal cells and their role in regulating apoptosis both in vitro and in vivo.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!